18 March 2026
Verovaccines Receives Recommendation from EMA for Approval of VeroBlue‑3, the First Member of a New Vaccine Class
- Positive opinion by CVMP
- First-in-class innovation
- New active substance for BTV vaccines
- First DIVA-enabled BTV vaccine
18 March 2026